Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kala Azar”

211 trials

Showing 20 of 211 results

Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Not applicableStudy completedNCT05533736
What this trial is testing

Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia

Who this might be right for
Cutaneous Leishmaniasis, American
Centro Internacional de Entrenamiento e Investigaciones Médicas 105
Not applicableWithdrawnNCT02427308
What this trial is testing

Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry

Who this might be right for
Leishmaniasis or Other Uses of Miltefosine
Knight Therapeutics (USA) Inc
Testing effectiveness (Phase 2)Study completedNCT01011309
What this trial is testing

The Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Access to Advanced Health Institute (AAHI) 45
Testing effectiveness (Phase 2)Study completedNCT01300975
What this trial is testing

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

Who this might be right for
LeishmaniasisCutaneous Leishmaniasis
Fundacion Nacional de Dermatologia 90
Large-scale testing (Phase 3)Study completedNCT03829917
What this trial is testing

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis, American
Fundacion Nacional de Dermatologia 120
Testing effectiveness (Phase 2)Study completedNCT00373568
What this trial is testing

Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

Who this might be right for
Leishmaniasis
AB Foundation 25
Not applicableStudy completedNCT00401297
What this trial is testing

Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes

Who this might be right for
Leishmaniasis
Yale University 122
Early research (Phase 1)Study completedNCT02071758
What this trial is testing

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Visceral Leishmaniasis
Access to Advanced Health Institute (AAHI) 39
Early research (Phase 1)Study completedNCT03929016
What this trial is testing

Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects

Who this might be right for
Visceral LeishmaniasisCutaneous Leishmaniases
Drugs for Neglected Diseases 64
Early research (Phase 1)Ended earlyNCT06124144
What this trial is testing

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Who this might be right for
Leishmaniasis
University Hospital Tuebingen 13
Testing effectiveness (Phase 2)Study completedNCT00371995
What this trial is testing

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 150
Testing effectiveness (Phase 2)Study completedNCT00884377
What this trial is testing

Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
U.S. Army Medical Research and Development Command 56
Testing effectiveness (Phase 2)Study completedNCT00996463
What this trial is testing

Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients

Who this might be right for
Wound Healing
Waisenmedizin e. V. Promoting Access to Essential Medicine 63
Not applicableStudy completedNCT01769612
What this trial is testing

Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia

Who this might be right for
Skin Diseases, Parasitic
U.S. Army Medical Research and Development Command 168
Large-scale testing (Phase 3)Study completedNCT00523965
What this trial is testing

Combination Therapy in Indian Visceral Leishmaniasis

Who this might be right for
Leishmaniasis, Visceral
Banaras Hindu University 624
Large-scale testing (Phase 3)Study completedNCT03023111
What this trial is testing

Miltefosine and GM-CSF in Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Hospital Universitário Professor Edgard Santos 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05593666
What this trial is testing

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 101
Not applicableStudy completedNCT02979002
What this trial is testing

Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco

Who this might be right for
Cutaneous LeishmaniasisSkin Diseases, ParasiticNeglected Diseases
National School of Public Health, Morocco 219
Early research (Phase 1)Study completedNCT00111553
What this trial is testing

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Who this might be right for
Leishmaniasis, Cutaneous
Access to Advanced Health Institute (AAHI) 45
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation